Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer

J Halder, D Pradhan, B Kar, G Ghosh, G Rath - … , Biology and Medicine, 2022 - Elsevier
Multidrug resistance (MDR) in cancer chemotherapy is a growing concern for medical
practitioners. P-glycoprotein (P-gp) overexpression is one of the major reasons for multidrug …

Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia

C Dai Phung, TH Tran, HT Nguyen, JH Jeong… - Journal of Controlled …, 2020 - Elsevier
Hypoxia is a common feature of the tumor microenvironment, which is characterized by
tissue oxygen deficiency due to an aggressive proliferation of cancer cells. Hypoxia …

Manganese Dioxide‐Based Nanocarrier Delivers Paclitaxel to Enhance Chemotherapy against Orthotopic Glioma through Hypoxia Relief

S Jiang, X Li, F Zhang, J Mao, M Cao, X Zhang… - Small …, 2022 - Wiley Online Library
Chemotherapy plays an important role in treating cancers in clinic. Hypoxia‐mediated
chemoresistance remains a major hurdle for effective tumor chemotherapy. Herein, a new …

Evaluation of the anti-oxidative and ROS scavenging properties of biomaterials coated with epigallocatechin gallate for tissue engineering

S Lee, J Lee, H Byun, S Kim, J Joo, HH Park - Acta Biomaterialia, 2021 - Elsevier
In tissue engineering, excessively generated reactive oxygen species (ROS) during
biomaterial implantation or cell transplantation is a one of major causes of diminishing …

Nanomaterials relieving hypoxia for enhanced tumor therapy

L Hao, L Wang, Y Ma, M Bottini, L Li, HB Cheng… - Coordination Chemistry …, 2024 - Elsevier
Hypoxia is a hallmark of solid tumors and it significantly contributes to the development of
key biological features of tumors, including the microenvironment, migration, invasion …

A DNA‐Gated and Self‐Protected Bioorthogonal Catalyst for Nanozyme‐Assisted Safe Cancer Therapy

Y Zhang, L Zhang, W Wang, Q Deng… - Angewandte Chemie …, 2023 - Wiley Online Library
Transition metal catalysts (TMCs) mediated bioorthogonal uncaging catalysis has sparked
increasing interest in prodrug activation. However, due to their “always‐on” catalytic activity …

Antioxidants and nanotechnology: promises and limits of potentially disruptive approaches in the treatment of central nervous system diseases

C Martinelli, C Pucci, M Battaglini… - Advanced …, 2020 - Wiley Online Library
Many central nervous system (CNS) diseases are still incurable and only symptomatic
treatments are available. Oxidative stress is suggested to be a common hallmark, being able …

[HTML][HTML] Catalase application in cancer therapy: Simultaneous focusing on hypoxia attenuation and macrophage reprogramming

A Najafi, M Keykhaee, H Khorramdelazad… - Biomedicine & …, 2022 - Elsevier
The tumor microenvironment (TME), as an immunosuppressive milieu, has a critical role in
tumor progression and increases resistance to the conventional treatments. Among the …

Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance

VM Khot, AB Salunkhe, S Pricl, J Bauer, ND Thorat… - Drug Discovery …, 2021 - Elsevier
Highlights•A systematic review on how new generation molecular nanomedicine allows
chemoresistant cancer management.•Recent developments in molecular targeting …

Oxygen-based nanocarriers to modulate tumor hypoxia for ameliorated anti-tumor therapy: fabrications, properties, and future directions

X Li, Y Wu, R Zhang, W Bai, T Ye… - Frontiers in Molecular …, 2021 - frontiersin.org
Over the past five years, oxygen-based nanocarriers (NCs) to boost anti-tumor therapy
attracted tremendous attention from basic research and clinical practice. Indeed, tumor …